vs

Side-by-side financial comparison of Dexcom (DXCM) and Qnity Electronics, Inc. (Q). Click either name above to swap in a different company.

Qnity Electronics, Inc. is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× Dexcom). Dexcom runs the higher net margin — 21.2% vs 12.3%, a 8.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 10.5%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

DXCM vs Q — Head-to-Head

Bigger by revenue
Q
Q
1.0× larger
Q
$1.3B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+11.1% gap
DXCM
21.6%
10.5%
Q
Higher net margin
DXCM
DXCM
8.9% more per $
DXCM
21.2%
12.3%
Q

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
Q
Q
Revenue
$1.3B
$1.3B
Net Profit
$267.3M
$162.0M
Gross Margin
62.9%
47.0%
Operating Margin
25.6%
Net Margin
21.2%
12.3%
Revenue YoY
21.6%
10.5%
Net Profit YoY
153.6%
48.6%
EPS (diluted)
$0.67
$0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
Q
Q
Q1 26
$1.3B
$1.3B
Q4 25
$1.3B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
Q1 25
$1.0B
Q4 24
$1.1B
Q3 24
$994.2M
$1.1B
Q2 24
$1.0B
Net Profit
DXCM
DXCM
Q
Q
Q1 26
$267.3M
$162.0M
Q4 25
$267.3M
Q3 25
$283.8M
$211.0M
Q2 25
$179.8M
Q1 25
$105.4M
Q4 24
$151.7M
Q3 24
$134.6M
$199.0M
Q2 24
$143.5M
Gross Margin
DXCM
DXCM
Q
Q
Q1 26
62.9%
47.0%
Q4 25
62.9%
Q3 25
60.5%
45.1%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
47.0%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
Q
Q
Q1 26
25.6%
Q4 25
25.6%
Q3 25
20.1%
21.3%
Q2 25
18.4%
Q1 25
12.9%
Q4 24
17.0%
Q3 24
15.3%
21.8%
Q2 24
15.7%
Net Margin
DXCM
DXCM
Q
Q
Q1 26
21.2%
12.3%
Q4 25
21.2%
Q3 25
23.5%
16.5%
Q2 25
15.5%
Q1 25
10.2%
Q4 24
13.6%
Q3 24
13.5%
17.3%
Q2 24
14.3%
EPS (diluted)
DXCM
DXCM
Q
Q
Q1 26
$0.67
$0.72
Q4 25
$0.67
Q3 25
$0.70
$1.01
Q2 25
$0.45
Q1 25
$0.27
Q4 24
$0.37
Q3 24
$0.34
$0.95
Q2 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
Q
Q
Cash + ST InvestmentsLiquidity on hand
$917.7M
$857.0M
Total DebtLower is stronger
$4.0B
Stockholders' EquityBook value
$2.7B
$7.5B
Total Assets
$6.3B
$14.1B
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
Q
Q
Q1 26
$917.7M
$857.0M
Q4 25
$917.7M
Q3 25
$1.8B
$128.0M
Q2 25
$1.2B
Q1 25
$904.9M
Q4 24
$606.1M
Q3 24
$621.2M
Q2 24
$939.2M
Total Debt
DXCM
DXCM
Q
Q
Q1 26
$4.0B
Q4 25
Q3 25
$1.7B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
Q
Q
Q1 26
$2.7B
$7.5B
Q4 25
$2.7B
Q3 25
$2.7B
$9.1B
Q2 25
$2.6B
Q1 25
$2.3B
Q4 24
$2.1B
Q3 24
$2.0B
$11.1B
Q2 24
$2.4B
Total Assets
DXCM
DXCM
Q
Q
Q1 26
$6.3B
$14.1B
Q4 25
$6.3B
Q3 25
$7.5B
$12.5B
Q2 25
$7.3B
Q1 25
$6.8B
Q4 24
$6.5B
Q3 24
$6.4B
Q2 24
$6.8B
Debt / Equity
DXCM
DXCM
Q
Q
Q1 26
0.54×
Q4 25
Q3 25
0.19×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons